Institutional Ownership Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX). We have compiled data on the 141 institutions that hold shares in the stock, with a total of 48.9 Million shares, which have been reported (via 13F filing form) to have a value of $179 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Walleye Capital LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
518,784
shares
|
$1.9 Million
0.01% of portfolio
|
Q4 2024
Reduced 22.64%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
472,397
shares
|
$1.73 Million
0.01% of portfolio
|
Q4 2024
Added 862.48%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
464,400
shares
|
$1.7 Million
0.0% of portfolio
|
Q4 2024
Added 70.86%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
464,220
shares
|
$1.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.94%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
348,000
shares
|
$1.27 Million
0.04% of portfolio
|
Q4 2024
New holding
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
325,000
shares
|
$1.19 Million
0.39% of portfolio
|
Q3 2024
New holding
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
314,939
shares
|
$1.15 Million
0.0% of portfolio
|
Q4 2024
Reduced 34.17%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
306,744
shares
|
$1.12 Million
0.0% of portfolio
|
Q4 2024
Reduced 55.61%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
298,949
shares
|
$1.09 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.1%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
295,000
shares
|
$1.08 Million
1.83% of portfolio
|
Q3 2023
Added 1080.0%
|
|
|
Aldebaran Capital, LLC
Indianapolis, IN |
Feb 12, 2025 Q4 2024 |
262,753
shares
|
$961,675
0.94% of portfolio
|
Q4 2024
Reduced 2.61%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
241,400
shares
|
$883,524
0.0% of portfolio
|
Q4 2024
Reduced 22.0%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
218,383
shares
|
$799,281
0.0% of portfolio
|
Q4 2024
Added 40.98%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
202,316
shares
|
$740,476
0.0% of portfolio
|
Q4 2024
Added 8.61%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
201,187
shares
|
$736,344
0.13% of portfolio
|
Q4 2024
Reduced 26.72%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
193,931
shares
|
$709,787
0.0% of portfolio
|
Q4 2024
Added 16.52%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
188,386
shares
|
$689,492
0.0% of portfolio
|
Q4 2024
Reduced 70.98%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
184,678
shares
|
$675,921
0.0% of portfolio
|
Q4 2024
Reduced 34.97%
|
|
|
Alpha Wave Global, LP
New York, NY |
Feb 13, 2025 Q4 2024 |
148,627
shares
|
$543,974
0.64% of portfolio
|
Q4 2024
Reduced 77.8%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
146,500
shares
|
$536,190
0.01% of portfolio
|
Q4 2024
Added 12.69%
|
|
|
Bank Of Montreal
Toronto, A6 |
Feb 13, 2025 Q4 2024 |
143,512
shares
|
$525,253
0.0% of portfolio
|
Q3 2024
Added 36.35%
|
|
|
Kennondale Capital Management LLC
Richmond, VA |
Feb 10, 2025 Q4 2024 |
134,445
shares
|
$492,068
0.57% of portfolio
|
Q4 2024
New holding
|
|
|
Mackenzie Financial Corp
Toronto Ontario, A6 |
Feb 20, 2025 Q4 2024 |
111,310
shares
|
$407,394
0.0% of portfolio
|
Q4 2024
Added 234.87%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
106,564
shares
|
$390,024
0.0% of portfolio
|
Q4 2024
Added 11.76%
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Feb 12, 2025 Q4 2024 |
106,237
shares
|
$388,827
0.0% of portfolio
|
Q4 2024
New holding
|